Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amedisys Inc (AMED)

Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Amedisys Inc 3854 AMERICAN WAY SUITE A BATON ROUGE LA 70816 USA

www.amedisys.com Employees: 19,000 P: 225-292-2031

Description:

Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).

Key Statistics

Overview:

Market Capitalization, $K 3,138,298
Enterprise Value, $K 3,397,608
Shares Outstanding, K 32,677
Annual Sales, $ 2,236 M
Annual Net Income, $ -9,750 K
Last Quarter Sales, $ 591,190 K
Last Quarter Net Income, $ 32,300 K
EBIT, $ 177,290 K
EBITDA, $ 236,120 K
60-Month Beta 0.78
% of Insider Shareholders 1.80%
% of Institutional Shareholders 94.36%
Float, K 32,089
% Float 98.20%
Short Volume Ratio 0.67

Growth:

1-Year Return 3.41%
3-Year Return -34.34%
5-Year Return -26.08%
5-Year Revenue Growth 34.51%
5-Year Earnings Growth 18.46%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.32 on 07/24/24
Next Earnings Date 10/22/24
Earnings Per Share ttm 4.27
EPS Growth vs. Prev Qtr 28.16%
EPS Growth vs. Prev Year -3.65%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 4-3 on 12/05/06

AMED Ratios

Ratio
Price/Earnings ttm 22.47
Price/Earnings forward 20.57
Price/Earnings to Growth 1.88
Return-on-Equity % 12.39%
Return-on-Assets % 6.78%
Profit Margin % -0.44%
Debt/Equity 0.33
Price/Sales 1.40
Price/Cash Flow 15.68
Price/Book 2.66
Book Value/Share 36.01
Interest Coverage 2.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar